7Baggers
 Viridian Therapeutics stock hits 52-week high at $29.27 By Investing.com  Investing.com Canada Sat, 15 Nov 2025 07:22:06 GMT
 viridian therapeutics stock hits 52-week high at $29.27 by investing.com  Investing.com South Africa Fri, 14 Nov 2025 15:34:09 GMT
 Viridian Therapeutics at Stifel 2025: Strategic Moves in TED Market  Investing.com Wed, 12 Nov 2025 16:48:25 GMT
 H.C. Wainwright Sticks to Their Buy Rating for Viridian Therapeutics (VRDN)  The Globe and Mail Tue, 11 Nov 2025 01:24:43 GMT
 best biotech stocks to consider - november 6th  MarketBeat Mon, 10 Nov 2025 08:00:00 GMT
 best biotech stocks to consider - november 6th  MarketBeat Fri, 07 Nov 2025 19:13:30 GMT
 vrdn - viridian therapeutics inc latest stock news & market updates  Stock Titan Fri, 07 Nov 2025 12:00:00 GMT
 Viridian Therapeutics Scores Relative Strength Rating Upgrade  Investor's Business Daily Fri, 07 Nov 2025 08:00:00 GMT
 symbol__ stock quote price and forecast  CNN Thu, 06 Nov 2025 23:23:34 GMT
 How buybacks impact Viridian Therapeutics Inc. stock value  newser.com Thu, 06 Nov 2025 22:43:51 GMT
 Viridian Therapeutics Is Ready For An Eventful 2026 (NASDAQ:VRDN)  Seeking Alpha Thu, 06 Nov 2025 08:00:00 GMT
 Viridian Therapeutics stock hits 52-week high at $27.22  Investing.com Thu, 06 Nov 2025 08:00:00 GMT
 Why Viridian Therapeutics Shares Are Soaring  TipRanks Thu, 06 Nov 2025 08:00:00 GMT
 viridian therapeutics stock price target raised to $48 by stifel  Investing.com Wed, 05 Nov 2025 17:56:41 GMT
 Viridian Therapeutics Attracts Cash And Analyst Confidence  Finimize Wed, 05 Nov 2025 15:46:36 GMT
 viridian therapeutics reports q3 eps (34c), consensus (94c)  TipRanks Wed, 05 Nov 2025 15:10:13 GMT
 viridian files bla for veligrotug in thyroid eye disease  The Pharma Letter Wed, 05 Nov 2025 14:19:09 GMT
 viridian therapeutics q3 net loss narrows, revenue rises  MarketScreener Wed, 05 Nov 2025 14:17:00 GMT
 viridian therapeutics: what’s behind the stock movement?  TipRanks Wed, 05 Nov 2025 13:49:03 GMT
 Viridian Therapeutics, Inc.\DE SEC 10-Q Report  TradingView Wed, 05 Nov 2025 13:03:00 GMT
 viridian therapeutics secures $889 mln financing  MarketScreener Wed, 05 Nov 2025 12:24:22 GMT
 Viridian Therapeutics Q3 2025 Financial Results  TradingView Wed, 05 Nov 2025 12:15:00 GMT
 BRIEF-Viridian Therapeutics Q3 Net Income USD -34.599 Million  TradingView Wed, 05 Nov 2025 12:01:46 GMT
 Viridian Therapeutics earnings beat by $0.61, revenue topped estimates  Investing.com Wed, 05 Nov 2025 08:00:00 GMT
 viridian therapeutics, inc. - common stock (nq: vrdn  FinancialContent Tue, 04 Nov 2025 20:57:28 GMT
 viridian submits bla for veligrotug to treat ted  Eyes On Eyecare Tue, 04 Nov 2025 11:39:42 GMT
 vrdn: btig reiterates 'buy' rating and price target at $61.00 |  GuruFocus Tue, 04 Nov 2025 10:46:17 GMT
 viridian therapeutics submits bla for thyroid disease drug  Traders Union Mon, 03 Nov 2025 13:00:13 GMT
 viridian therapeutics (vrdn) submits bla for veligrotug to fda  GuruFocus Mon, 03 Nov 2025 12:56:00 GMT
 viridian therapeutics submits bla to the fda for veligrotug  TipRanks Mon, 03 Nov 2025 12:29:27 GMT
 chart based analysis of viridian therapeutics inc. trends  newser.com Mon, 03 Nov 2025 09:47:17 GMT
 Viridian Therapeutics Stock Dips Amid FDA Submission  TipRanks Mon, 03 Nov 2025 08:00:00 GMT

Viridian Therapeutics, Inc.
(NASDAQ:VRDN) 

VRDN stock logo

Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody for the treatment of thyroid eye disease; VRDN-002, a biosuperior IGF-1R antibody; and VRDN-003, an IGF-1R antibod...

Founded: 2006
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends